Meadow Creek Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

Meadow Creek Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$165K	Hold	2,268	–	–	﹤0.01%	1084
2019 Q2	$186K	Hold	2,268	–	–	﹤0.01%	1059
2019 Q1	$160K	Hold	2,268	–	–	﹤0.01%	1083
2018 Q4	$102K	Hold	2,268	–	–	﹤0.01%	1143
2018 Q3	$128K	Buy	2,268 +476	+27%	+$29.1K	﹤0.01%	1186
2018 Q2	$120K	Hold	1,792	–	–	﹤0.01%	1152
2018 Q1	$104K	Hold	1,792	–	–	﹤0.01%	1191
2017 Q4	$116K	Buy	1,792 +252	+16%	+$15.7K	﹤0.01%	1165
2017 Q3	$81K	Buy	1,540 +252	+20%	+$12K	﹤0.01%	1184
2017 Q2	$60K	Buy	1,288 +728	+130%	+$35.1K	﹤0.01%	1218
2017 Q1	$28K	Buy	+560	New	+$31.4K	﹤0.01%	1256

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Meadow Creek Investment Management's ANIP Position: Q3 2019 in Review

Meadow Creek Investment Management held its ANI Pharmaceuticals (ANIP) position steady in Q3 2019 at 2,268 shares worth $165K. The position accounts for ﹤0.01% of the portfolio, ranked #1084.

Meadow Creek Investment Management first reported a position in ANIP in Q1 2017 and has held it in 11 quarters since. The position peaked at $186K in Q2 2019. 190 funds tracked by Wall St. Rank hold ANIP as of Q3 2019.

Meadow Creek Investment Management held 2,268 shares of ANI Pharmaceuticals worth $165K as of Q3 2019.
Meadow Creek Investment Management left its ANI Pharmaceuticals share count unchanged in Q3 2019.
ANI Pharmaceuticals made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #1084 holding.
Meadow Creek Investment Management first reported a position in ANI Pharmaceuticals in Q1 2017 and has held it in 11 quarters since.
Meadow Creek Investment Management's ANI Pharmaceuticals position peaked at $186K in Q2 2019.
190 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.